Renal Cancer Research by Sengenics and the University of Leeds Awarded...

This collaboration will focus on discovery of novel biomarkers for renal cell carcinoma (RCC), with the goal of developing an autoantibody-based early diagnostic test for this disease(PRWeb November 26, 2019)Read the full story at https://www.prweb.com/releases/renal_cancer_research_by_sengenics_and_the_university_of_leeds_awarded_early_detection_primer_grant_funding_from_cancer_research_uk/prweb16740467.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news